Chlorhexidine
Regulatory activity · MHRAAlso known as Avagard, Bactoshield, Betasept, CHG Teat Dip+44 more
Avagard, Bactoshield, Betasept, CHG Teat Dip, Calgon Vesta, ChloraPrep, ChloraPrep One-Step, Chlorhexidine Gluconate, Chlorostat, Chlorostat 4, Cloresidina, Clorhexidina, Dyna-Hex, E-Z Scrub, Exidine, Hibiclens, Hibistat, Keto-C, Ketochlor, Mal-A-Ket, Mal-A-Ket Wipes, Malaseb, Maxiclens, MiconaHex+Triz, Nolvadent, Nolvasan, Nupro Chlorhexidine, Oro Clense, Otodine, Paroex, Peridex, PerioChip, Periogard, Perisol, Prevantics, Scrub Care Exidine, Scrub-Stat, Soluprep, Spectrum-4, Stomodine F, Suffusion, Supreme, Tru-Blu C-Hex 110, Tru-Blu Chlor Hex-Wash, Chlorhexidin, 1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide), Chlorhexidinum, N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide.
Recent clinical, regulatory, research and industry developments relating to this drug.
Antiseptic Effects on the Dental Implant Internal Surface Microbiome
Drug Safety Update: Chlorhexidine: reminder of potential for hypersensitivity
Guidelines for the prevention of intravascular catheter-related infections.
Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Regulatory timeline
The complete regulatory record, grouped by authority — approvals, safety advisories and label changes. Each authority shows its most recent events; expand one to read its full history.
Contains public sector information from the Medicines and Healthcare products Regulatory Agency (MHRA) licensed under the Open Government Licence (OGL v3).
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Effects of Irrisept Irrigation in Emergency General Surgery Cases on SSI Rates
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes2
Journals, researchers & institutions
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America1
- Critical care medicine1
- Journal of applied microbiology1
- The New England journal of medicine1
- Alexander M1
- Alsharif A1
- Ashton CM1
- Awad SS1
- Barão VAR1
- Berger DH1
- Bersamin JB1
- Bertolini M1
- 1Department of Pharmacy Practice and Clinical Health Sciences1
- Guarulhos University1
- Harvard School of Dental Medicine1
- Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine1
- National Institutes of Health1
- Piracicaba Dental School1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials
- Regulatory event sources are credited in the Regulatory Timeline above.